Cohort Study on Febrile Neutropenia in Adjuvant Chemotherapy for Breast Cancer Patients
Not Applicable
- Conditions
- Breast Cancer
- Registration Number
- JPRN-UMIN000017857
- Lead Sponsor
- CSPOR-BC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with no chemotherapy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of Febrile Neutropenia
- Secondary Outcome Measures
Name Time Method 1) FN in 1st. cycle 2)Grade 4 FN 3)Hospitalization 4) G-CSF 5)Antibiotics 6)Adverse events with FN and RDI 7) Patients with G-CSF 8) FN with or without G-CSF 9) Severe adverse events